Cumberland Pharmaceuticals (CPIX) Total Liabilities (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Total Liabilities across 17 years of filings, most recently posting $49.7 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $49.7 million, up 19.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.7 million (up 19.47% YoY), and the FY2025 annual result was $52.3 million, down 1.43% from the prior year.
• Total Liabilities came in at $49.7 million for Q1 2026 at Cumberland Pharmaceuticals, down from $52.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $57.0 million in Q4 2022 to a low of $40.1 million in Q3 2025.
• The 5-year median for Total Liabilities is $52.5 million (2024), against an average of $50.9 million.
• Across the five-year window, Total Liabilities jumped 36.06% in 2022 and slipped 23.43% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Total Liabilities stood at $57.0 million in 2022, then dropped by 7.79% to $52.5 million in 2023, then climbed by 0.99% to $53.0 million in 2024, then declined by 1.43% to $52.3 million in 2025, then dropped by 4.95% to $49.7 million in 2026.
• The last three Total Liabilities figures came in at $49.7 million (Q1 2026), $52.3 million (Q4 2025), and $40.1 million (Q3 2025), per Business Quant data.